Tag: gut
A gut microbial signature for
CA209-538: clinical trial procedures CA209-538, titled ‘A phase 2 trial of ipilimumab and nivolumab for the treatment of rare cancers’, is an investigator-initiated, prospective, multicenter, [Read More…]
